Home/3Z Pharmaceuticals/Dagmar Þ. Halldórsdóttir

DÞ

Dagmar Þ. Halldórsdóttir

Project Manager

3Z Pharmaceuticals

Therapeutic Areas

Central Nervous System (CNS) Disorders Neurology

3Z Pharmaceuticals Pipeline

Drug	Indication	Phase
3Z-20-001	Neurological Indication (Undisclosed)	Preclinical
3Z-20-002	Neurological Indication (Undisclosed)	Preclinical
3Z-20-003	Neurological Indication (Undisclosed)	Preclinical
3Z-20-004	Neurological Indication (Undisclosed)	Preclinical
3Z-20-005	Neurological Indication (Undisclosed)	Preclinical

Leadership Team at 3Z Pharmaceuticals

Karl Æ. Karlsson

CEO & Co-founder

Haraldur Þorsteinsson

CSO & Co-founder

Hildur S. Sveinsdóttir

Manager of Lab Operations

Ólafur Þ. Arason

Technical Manager

View full 3Z Pharmaceuticals profile